VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CNO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CNOCNO Financial Group, Inc.
$53.86$5.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCNOCash Flow

CNO Financial Group, Inc. (CNO) Cash Flow Statement

24Y historyFree accessUpdated daily

Operating cash flow of $156.6M in 2026Q2 exceeded net income (OCF/NI of 1.24), fully covering $77.6M in dividends and buybacks, but net investment outflows of $600M in the quarter may indicate reliance on portfolio turnover to sustain yields.

Income StatementBalance SheetCash FlowRatios

CNO Cash Flow Statement

Annual statement

CNO Cash Flow Statement

CNO Financial Group, Inc. (CNO) cash flow statement — 24-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02
Cash from Operations698.9M675.7M627.7M582.9M495.4M598.3M735.5M696.7M317.8M613.1M759.5M743.9M121.8M720.4M634.9M774.8M734M644M986.8M703.3M931.2M1.16B1.05B1.19B1.3B
Operating CF Growth %4.49%7.65%7.69%17.66%-17.2%-18.65%5.57%119.23%-48.17%-19.28%2.1%510.76%-83.09%13.47%-18.06%5.56%13.98%-34.74%40.31%-24.47%-19.87%10.93%-11.7%-8.44%-
Operating CF / Revenue %15.04%15.06%14.12%14.06%13.85%14.51%19.25%17.35%7.37%14.25%19.02%19.57%2.94%16.09%14.62%18.78%17.97%14.83%23.55%17.02%20.84%26.86%24.17%25.19%29.11%
Net Income279.6M229.3M404M276.5M630.6M570.3M301.8M278M-315M175.6M358.2M270.7M51.4M478M221M382.5M284.6M85.7M-1.13B-179.9M96.5M324.9M294.8M00
Depreciation & Amortization161.9M318.5M292.4M267.4M248.5M236.6M303.9M267.9M292.2M265.4M275M283.4M274.2M324.6M315M458.6M465.3M460.9M412M483.2M00000
Stock-Based Compensation0000025.2M018.8M24.7M21.4M23M17.1M15.6M15.1M15M0000000000
Deferred Taxes-6M26.3M59.1M21.1M152M146.5M14.1M-132.8M18.4M227.5M-11.7M92.9M119.7M-181.2M-71.8M0000000000
Other Non-Cash Items74.6M-516.5M-684.1M-431.8M-161M-726.5M-281.9M-367.6M728.2M-233.7M-19.2M9.3M-682M-110.4M113.5M-41.8M18.2M115M1.26B-315.1M1.32B1.24B1.12B1.07B0
Working Capital Changes352.4M618.1M556.3M449.7M-374.7M346.2M397.6M632.4M207.8M464.7M332.8M297.4M398.2M465.8M330M-24.5M-34.1M-17.6M437.5M715.1M-484.7M-400.9M-364.4M115.7M0
Cash from Investing-1.79B-1.67B-1.49B-872.3M-1.78B-1.53B-608.4M-555.6M-525.7M-239.6M-742.4M-1.07B56.3M-602.5M-197.1M-1.34B-1.3B-922.7M-629.8M-1.13B-1.05B-1.55B-1.46B422.5M3.41B
Capital Expenditures0000000000000000000000000
Acquisitions000000000000231M000000000000
Purchase of Investments-13.92B-8.46B-6.89B-3.62B-6.52B-6.15B-4.28B-5.59B-6.21B-6.14B-6.24B-4.78B-3.73B-5.37B-4.27B-8.16B-10.74B-12.54B-8.19B-9.25B-9.49B-14.45B-16B-12.98B-27.76B
Sale/Maturity of Investments12.13B6.8B5.42B2.79B4.8B4.7B3.71B5.14B5.71B5.92B5.35B4.03B3.71B4.84B4.09B6.9B9.53B11.63B7.53B8.14B9.5B12.94B14.6B13.42B31.76B
Other Investing-4M-3.2M-13.5M-36.6M-61.2M-75.3M-39.8M-102M-25M-19.5M152.6M-321.1M-156.2M-73.1M-11.4M-80.1M-86M-9.2M36.1M-21.3M-1.06B-31.6M-57.6M-18.2M-589.9M
Cash from Financing1.59B-22.6M1.97B533.5M1.2B667.6M210.1M-143M107.2M-274M26.2M146.4M-265.5M-1.4M-291.3M427.3M613.1M-92.4M175.6M447M268.1M-150.2M-44.4M-1.6B-6.5B
Dividends Paid-66.4M-66.2M-67.7M-68.1M-64.8M-65.7M-67M-67.1M-64.8M-59.6M-54.8M-52M-51M-24.4M-13.9M0000-19M-38M-38M-19.3M0-86.2M
Share Repurchases-255M-331.4M-300.2M-166.1M-190.1M-407.8M-268.3M-254.5M-108M-168.3M-210M-365.4M-376.5M-118.4M-180.2M-69.8M000-87.2M00-928.9M00
Stock Issued11.1M11.6M11.2M13.2M13.5M21.5M19M9.2M3.9M8.3M8.4M6.3M5M15.1M3.1M2.2M0296.3M03.4M1M500K882.2M00
Debt Issuance (Net)900K-1000K1000K1000K-1000K1000K1000K-1000K-100K-1000K1000K1000K1000K1000K1000K1000K1000K-1000K-1000K1000K1000K1000K-1000K0-1000K
Other Financing1.47B833M1.96B495.8M1.56B1.05B384.5M379.2M276.2M213.3M205.1M-4.8M-52.5M-240.5M-248.2M29.2M25.7M-1.2M290.1M-137.1M156.4M-196M-3.6M-1.6B-2.6B
Net Change in Cash490M-1.01B1.11B244.1M-86.8M-260.2M337.2M-1.9M-100.7M99.5M46.6M-179.3M-87.4M116.5M146.5M-135.9M48.5M-371.1M532.6M21.6M148.1M-538.8M-452.1M11.1M-1.79B
Exchange Rate Effect0000000000000000000000000
Cash at Beginning1.15B2B889M644.9M731.7M991.9M654.7M656.6M757.3M478.9M432.3M611.6M699M582.5M436M571.9M523.4M894.5M361.9M385.9M237.8M776.6M1.23B2.38B3.01B
Cash at End1.31B983.5M2B889M644.9M731.7M991.9M654.7M656.6M578.4M478.9M432.3M611.6M699M582.5M436M571.9M523.4M894.5M407.5M385.9M237.8M776.6M2.39B1.22B
Free Cash Flow698.9M675.7M627.7M582.9M495.4M598.3M735.5M696.7M317.8M613.1M759.5M743.9M121.8M720.4M634.9M774.8M734M644M986.8M703.3M931.2M1.16B1.05B1.19B1.3B
FCF Growth %-0.78%7.65%7.69%17.66%-17.2%-18.65%5.57%119.23%-48.17%-19.28%2.1%510.76%-83.09%13.47%-18.06%5.56%13.98%-34.74%40.31%-24.47%-19.87%10.93%-11.7%-8.44%-
FCF Margin %15.04%15.06%14.12%14.06%13.85%14.51%19.25%17.35%7.37%14.25%19.02%19.57%2.94%16.09%14.62%18.78%17.97%14.83%23.55%17.02%20.84%26.86%24.17%25.19%29.11%
FCF per Share7.366.915.815.064.214.565.144.431.923.564.263.810.563.12.262.552.433.335.344.066.116.287.211.8512.94

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Regulatory scrutiny on Medicare marketing

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Underwriting Cash Generation Strengthens

CNO's operating cash flow reached $156.6M in 2026Q2, up from $110.9M a year earlier, as reported in financial statements, indicating improved premium collection efficiency and claims management.

The OCF/NI ratio of 1.24 in 2026Q2, though lower than the unusually high 3.95 in 2026Q1, still indicates that cash generation exceeds net income, suggesting strong underwriting cash conversion. The consistent positive OCF across quarters, even when net income dipped to $9.3M in 2024Q3, underscores the stability of premium inflows relative to claims outflows. This pattern implies that CNO's core insurance operations are generating sufficient cash to cover claims and expenses, with the recent earnings beat likely supported by this cash flow strength.

Claims Payments Reflect Seasonality

Claims and loss payments averaged $660M per quarter over the last five quarters, with 2026Q2 at $727.2M, as per SEC filings, suggesting a rising trend that may pressure underwriting cash flows.

The increase in claims payments from $570.1M in 2026Q1 to $727.2M in 2026Q2, a 27.5% jump, appears to align with seasonal patterns observed in prior years, such as the spike in 2024Q3. However, the magnitude of the recent increase warrants monitoring, as it could indicate emerging morbidity trends in the legacy LTC block or higher utilization in supplemental health products. If claims continue to escalate without corresponding premium growth, the underwriting cash surplus could narrow, potentially affecting the company's ability to fund investment activities.

Investment Portfolio Churn Intensifies

Investment purchases outpaced sales by $600M in 2026Q2, with purchases at $4.3B and sales at $3.7B, as reported in financial statements, indicating active portfolio repositioning to capture higher yields.

The net investment outflow of $600M in 2026Q2, compared to a net inflow of $100M in 2026Q1, suggests that CNO is aggressively deploying cash into higher-yielding assets, likely in response to the higher-for-longer rate environment. This strategy appears to be enhancing the net investment spread, which is a key driver of profitability, as noted in company intelligence. However, the scale of purchases relative to sales also implies significant transaction costs and potential liquidity needs, which investors should monitor for impact on overall cash reserves.

Capital Returns Covered by Cash Flow

Dividends and buybacks totaled $77.6M in 2026Q2, fully covered by operating cash flow of $156.6M, as per recent earnings reports, indicating a sustainable capital return policy.

The payout ratio of approximately 50% of OCF in 2026Q2, consistent with prior quarters, suggests that CNO's capital returns are comfortably supported by underwriting cash generation, without relying on portfolio liquidation. The reduction in buybacks from $110.3M in 2025Q1 to $60.9M in 2026Q2 may reflect management's preference for redeploying capital into investment opportunities, but it still demonstrates a commitment to returning cash to shareholders. Given the stable OCF trend, the dividend appears secure, though investors should watch for any deviation in this coverage ratio.

Cash Earnings Outpace Reported Net Income

Operating cash flow exceeded net income in every quarter of the last two years, with OCF/NI ratios ranging from 0.84 to 24.86, as reported in SEC filings, indicating significant non-cash accruals in earnings.

The persistently higher OCF relative to net income, particularly in quarters like 2024Q3 (OCF/NI of 24.86), suggests that reported earnings are heavily influenced by non-cash items such as reserve releases and actuarial adjustments under LDTI. This divergence implies that cash generation is more stable than net income, which is prone to volatility from assumption changes. Investors should focus on OCF as a more reliable indicator of underlying performance, while recognizing that the gap may narrow as reserve releases taper off.

What Cash Flow Obscures

Despite strong operating cash flow, the $600M net investment outflow in 2026Q2, as per financial statements, may indicate a reliance on portfolio turnover to sustain yields, warranting scrutiny.

The cash flow statement reveals that CNO is actively managing its investment portfolio, but the large purchases and sales could mask underlying liquidity needs or a shift in asset allocation. Additionally, the claims payment trend, which rose to $727.2M in 2026Q2, may signal emerging pressure on underwriting cash flows that is not yet reflected in net income due to reserve releases. Investors should monitor whether the investment spread gains are sufficient to offset any deterioration in claims experience, as the cash flow data alone does not capture the credit risk of reinsurance recoverables or the potential for catastrophe-related losses.

CNO — Frequently Asked Questions

Quick answers to the most common questions about buying CNO stock.

How much cash does CNO Financial Group, Inc. (CNO) generate from operations?

CNO Financial Group, Inc. (CNO) generated $675.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is CNO Financial Group, Inc.'s free cash flow?

CNO Financial Group, Inc. (CNO) generated $675.7M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is CNO Financial Group, Inc.'s capital expenditure (CapEx)?

CNO Financial Group, Inc. (CNO) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does CNO Financial Group, Inc. distribute cash to shareholders?

In 2025, CNO Financial Group, Inc. (CNO) returned $66.2M to shareholders via cash dividends and spent $331.4M on share repurchases. This shows the company's commitment to returning capital to its equity investors.